ArticleJournal of cellular and molecular medicine2021

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma.

Yun Hsiao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.